Litigation Details for Novo Nordisk, Inc. v. Mylan Pharmaceuticals, Inc. (D. Del. 2022)
✉ Email this page to a colleague
Novo Nordisk, Inc. v. Mylan Pharmaceuticals, Inc. (D. Del. 2022)
Docket | ⤷ Sign Up | Date Filed | 2022-08-08 |
Court | District Court, D. Delaware | Date Terminated | 2024-10-02 |
Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | None | Referred To | Eleanor G. Tennyson |
Patents | 10,220,155; 10,335,462; 10,357,616; 10,376,652; 8,114,833; 8,129,343; 8,536,122; 8,684,969; 8,920,383; 9,108,002; 9,132,239; 9,457,154; 9,616,180; 9,687,611; 9,775,953; 9,861,757; RE46,363 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novo Nordisk, Inc. v. Mylan Pharmaceuticals, Inc.
Biologic Drugs cited in Novo Nordisk, Inc. v. Mylan Pharmaceuticals, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Novo Nordisk, Inc. v. Mylan Pharmaceuticals, Inc. (D. Del. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2022-03-18 | 1 | 1/09/2018 Novo Nordisk A/S 13 10,220,155 3/05/2019 Novo…following n Trademarks or BfPatents. ( Q the patent action involves 35 U.S.C. § 292.): DOCKET…PHARMACEUTICALS INC. PATENT OR DATE OF PATENT … □ Other Pleading PATENT OR DATE OF PATENT …INC. NOVO NORDISK A/S PATENT OR DATE OF PATENT | External link to document | |
2023-08-03 | 118 | Notice of Service | Contentions Regarding U.S. Patent Nos. 8,129,343; 8,536,122; 8,114,833; 8,920,383; 9,775,953; 9,457,154; …2022 2 October 2024 1:22-cv-01040 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |